| ORIGINAL ARTICLE
|Year : 2011 | Volume
| Issue : 3 | Page : 219--221
Hypofractionated radiotherapy as local hemostatic agent in advanced cancer
Malik Tariq Rasool1, Najmi Arshad Manzoor1, Syed Arshad Mustafa2, Lone Mohammad Maqbool1, Fir Afroz1
1 Department of Radiation Oncology, Regional Cancer Centre, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
2 Department of Radiation Oncology, Government Medical College, Srinagar, India
Purpose : Tumor bleeding continues to remain a challenge in an oncological setting, and radiotherapy has been studied as a local hemostatic agent. We studied the role of local radiotherapy in controlling bleeding at our center.
Materials and Methods : We reviewed 25 treated cases (cancer urinary bladder: 12, lung cancer: 5, cervical cancer: 4, uterine cancer: 1, rectal cancer: 2, schwanoma: 1) at our center from March 2008 to December 2010. All patients had either an advanced or recurrent disease. Radiotherapy schedule was either 20 Gray in 5 fractions or 15 Gray in 5 fractions and was delivered with Cobalt 60.
Results and Conclusion : Of 25 patients, 22 (88%) responded, and there was complete cessation of bleeding. Both 15 Gray and 20 Gray dose schedule had equal efficacy. Treatment was well tolerated without any intermission. Radiotherapy is a safe and effective option in controlling tumor bleeding.
Malik Tariq Rasool
Department of Radiation Oncology, Regional Cancer Centre, Sher-i-Kashmir Institute of Medical Sciences, Srinagar
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*